SARS-CoV Spike 抗体
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| SARS-CoV Spike 抗体 (Cy5) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (Cy3) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (HRP) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (Biotin) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (N-Term) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (RBD) | SARS Coronavirus (SARS-CoV) | 小鼠 Monoclonal |
|
|
|
| SARS-CoV Spike 抗体 | SARS Coronavirus (SARS-CoV) | 小鼠 Monoclonal |
|
|
|
| SARS-CoV Spike 抗体 | SARS Coronavirus (SARS-CoV) | 小鼠 Monoclonal |
|
|
|
| SARS-CoV Spike 抗体 | SARS Coronavirus (SARS-CoV) | 小鼠 Monoclonal |
|
|
|
| SARS-CoV Spike 抗体 (Internal Region) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (Internal Region) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (Internal Region) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
|
| SARS-CoV Spike 抗体 (C-Term) | SARS Coronavirus (SARS-CoV) | 兔 Polyclonal |
|
|
- IF (Immunofluorescence: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- IF (Immunofluorescence: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy3
- 抗体亚型
- IgG
- ELISA (ELISA: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- ELISA (ELISA: 所列应用)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- N-Term
- Neut (Neutralization: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- COV1-62
- 标记
- unconjugated
- 抗体亚型
- IgG1 lambda
- 抗原表位
- RBD
- Neut (Neutralization: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- COV1-80
- 标记
- unconjugated
- 抗体亚型
- IgG1 lambda
- Neut (Neutralization: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- COV1-57
- 标记
- unconjugated
- 抗体亚型
- IgG1 kappa
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- COV1-100
- 标记
- unconjugated
- 抗体亚型
- IgG1 lambda
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Internal Region
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Internal Region
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- Internal Region
- ELISA (ELISA: 所列应用)
- 适用
- SARS Coronavirus (SARS-CoV)
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- C-Term
Latest Publications for our SARS-CoV Spike 抗体
: "Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry." in: Nature communications, Vol. 12, Issue 1, pp. 250, (2021) (PubMed).
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." in: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
: "Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats." in: BMC infectious diseases, Vol. 21, Issue 1, pp. 871, (2021) (PubMed).
: "38" in: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV." in: Nature communications, Vol. 11, Issue 1, pp. 1620, (2020) (PubMed).
: "Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles." in: Journal of medical virology, (2020) (PubMed).
: "Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States. ..." in: Emerging infectious diseases, Vol. 26, Issue 6, (2020) (PubMed).
: "COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2." in: PLoS pathogens, Vol. 16, Issue 8, pp. e1008762, (2020) (PubMed).
您还需要查找其他产品吗?
- SARS-Coronavirus Nucleocapsid Protein 抗体
- SARS-Coronavirus Nonstructural Protein 8 抗体
- SARS-Coronavirus Membrane Protein 抗体
- SARNP 抗体
- SARM1 抗体
- SARDH 抗体
- Sarcolemma Associated Protein 抗体
- Sarcalumenin 抗体
- SAR1B 抗体
- SAR1A 抗体
- SAPS2 抗体
- SAPS1 抗体
- SAP30BP 抗体
- SAP30-Like 抗体
- SAP30 抗体
- SAP18 抗体
- SAMM50 抗体
- SAMHD1 抗体
- SAMD9L 抗体
- SAMD9 抗体
- SARS-CoV-2 Non-Structural Protein 8 抗体
- SARS-CoV-2 Non-Structural Protein 9 抗体
- SARS-CoV-2 NSP12 (RdRP) 抗体
- SARS-CoV-2 NSP13 抗体
- SARS-CoV-2 NSP5 (3CL-Pro) 抗体
- SARS-CoV-2 Nucleocapsid 抗体
- SARS-CoV-2 Spike 抗体
- SARS-CoV-2 Spike S1 抗体
- SARS-CoV-2 Spike S2 抗体
- SARS2 抗体
- SART1 抗体
- SART3 抗体
- SASH1 抗体
- SASH3 抗体
- SAT1 抗体
- SAT2 抗体
- SATB1 抗体
- SATB2 抗体
- SAV1 抗体
- SBDS 抗体